Verification evidence is still being completed.
PDF / print export
DelSiTech
Turku, Finland
- Verified lead
- Sari Jalkanen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Drug Delivery, Controlled Release, Silica-Based Delivery Platforms, and Pharmaceutical Formulation Support
- Review cycle
- May 2026
- Full address
- Itaeinen Pitkakatu 2 C, PharmaCity, 20520 Turku, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official DelSiTech site confirming the PharmaCity Turku operating address.
- Editorial note
- DelSiTech is published because the official site confirms current leadership, the PharmaCity Turku operating address, and a real drug-delivery technology platform.
Drug Delivery, Controlled Release, Silica-Based Delivery Platforms, and Pharmaceutical Formulation Support
Official leadership disclosure, Official Turku address disclosure, Drug-delivery technology platform claim
DelSiTech is published because the official site confirms current leadership, the PharmaCity Turku operating address, and a real drug-delivery technology platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
DelSiTech runs controlled release platform development, drug delivery technology, and formulation support in Turku, Finland.
- Lead
- Sari Jalkanen (verified ↗)
- Address
- Itaeinen Pitkakatu 2 C, PharmaCity, 20520 Turku, Finland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Specialized drug-delivery platform
- Capabilities
- Controlled Release Platform Development · Drug Delivery Technology · Formulation Support
- Founded
- 2001
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Sari Jalkanen
CEO
Full addressItaeinen Pitkakatu 2 C, PharmaCity, 20520 Turku, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official DelSiTech terms and conditions page listing the PharmaCity Turku address.
Open sourceSpecialized drug-delivery platform
Turku, Finland. Drug Delivery, Controlled Release, Silica-Based Delivery Platforms, and Pharmaceutical Formulation Support. Review completed on 21 Mar 2026.
Finnish corporate and pharmaceutical-development oversight
Official leadership disclosure, Official Turku address disclosure, Drug-delivery technology platform claim
Drug Delivery, Controlled Release, Silica-Based Delivery Platforms, and Pharmaceutical Formulation Support
DelSiTech is published because the official site confirms current leadership, the PharmaCity Turku operating address, and a real drug-delivery technology platform.
Editorial note
DelSiTech is published because the official site confirms current leadership, the PharmaCity Turku operating address, and a real drug-delivery technology platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Controlled Release Platform Development
Drug Delivery Technology
Formulation Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Controlled-release development workflow
Silica-based platform systems
Formulation support infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is DelSiTech located?
- DelSiTech operates from Itaeinen Pitkakatu 2 C, PharmaCity, 20520 Turku, Finland, Turku, Finland.
- Who runs DelSiTech?
- DelSiTech is led by Sari Jalkanen, CEO. Verified 21 Mar 2026.
- What does DelSiTech do?
- DelSiTech runs controlled release platform development, drug delivery technology, and formulation support in Turku, Finland. Core capabilities: Controlled Release Platform Development, Drug Delivery Technology, Formulation Support.
Editorial context
Related technical briefs
Briefs that name Turku as a covered market or city.